Skip to content
Home/Companies/Healthcare/Anoat Therapeutics
AT

Anoat Therapeutics

Healthcare·France·Active·3yr hold

Anoat Therapeutics is a healthcare company, headquartered in France.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Anoat Therapeutics?

Anoat Therapeutics is currently owned by AdBio Partners through AFB Fund I (2021 vintage), since 2023.

Hand-verified · updated 2026-04-21

AdBio Partners
Investor
AdBio Partners
AFB Fund I · 2021 · VC

Key facts

HQFrance
SectorHealthcare

More from AFB Fund I

Other portfolio companies in the same fund.

Univercells
Exited 2023
BiotechBelgium
to
Orikine Bio
Active
HealthcareSpain· 2026
AndzonBio2
Active
HealthcareFrance· 2025
Cephagenix
Active
HealthcareDenmark· 2025
EvlaBio
Active
HealthcareGermany· 2025
AndzonBio1
Active
HealthcareFrance· 2024

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings